Tech Trailblazers : Respiree
Founded in 2019, Respiree’s technology is based on core sensor technology developed at the Singapore Bioimaging Consortium (SBIC), at A*STAR. Gurpreet Singh, Founder of Respiree and A*STAR scholar, shares how he turned a discovery in the lab into a device that could potentially save lives.
Tech wearables for early Covid-19 detection
Local medical technology start-up Respiree aims to deploy respiratory bio-markers to predict worsening conditions in Covid-19 patients in isolation rooms.
Non-invasive cardio-respiratory sensor to predict clinical deterioration in patients with respiratory diseases
Early identification and therapeutic intervention are key to reducing risk for individuals at risk of acute respiratory failure and pneumonia from COVID-19 – such is the core of the collaboration between the National University Hospital (NUH), NUS Yong Loo Lin School of Medicine (NUS Medicine) and Respiree Pte Ltd.